- Home
- A-Z Publications
- Current Vascular Pharmacology
- Previous Issues
- Volume 22, Issue 6, 2024
Current Vascular Pharmacology - Volume 22, Issue 6, 2024
Volume 22, Issue 6, 2024
- Medicine, Cardiology, Pharmacology, Peripheral Vascular Disease
-
-
-
Neovascularization as a Leading Mechanism of Intraplaque Hemorrhage and Carotid Plaque Destabilization: A Narrative Review
Authors: Arkadiusz Migdalski and Arkadiusz JawienIntraplaque neovascularization (IPN) is considered a leading mechanism causing carotid plaque destabilization. We provide an objective and comprehensive summary of the biology, imaging techniques, and treatment options related to carotid IPN. Plaque neovascularization has been reported to originate mainly from the adventitial vasa vasorum as a response to hypoxia. The leakage and rupture of neovessels lead to Read More
-
-
-
Comparison of Amiodarone Loading Dosage in the Treatment of Postoperative Atrial Fibrillation: High Versus Standard Dose Treatment
Authors: Ersin Sarıçam, Arslan Öcal, Murat Doğan İşcanlı, Engin Bozkurt, Erdoğan İlkay and Ömer Faruk CantekinBackgroundPostoperative atrial fibrillation (POAF) is associated with poor outcomes, including hemodynamic instability, stroke, myocardial infarction, and death. In hemodynamic stable patients, the rhythm-control strategy is more advantageous than rate control. Current standard intravenous amiodarone administration has limited success and a delayed effect; the acute success rate is 44% (8-12 h to several days). Read More
-
-
-
Association between Dietary Vitamin E Intake and the Risk of Hypertension in US Adults
More LessBackgroundMany studies have shown that Vitamin E (VitE) intake has beneficial effects on human health, but the relationship between VitE intake and Blood Pressure (BP) is not well understood. Thus, our present study aimed to assess the relationship between VitE intake and hypertension, systolic and diastolic BP in US (United States) adults.MethodsWe used data from the 2003-2018 National Health and Nutrition Examinatio Read More
-
-
-
Identification of Vascular Genes Differentially Expressed in the Brain of Patients with Alzheimer's Disease
BackgroundAlzheimer's disease (AD) plays a prominent role as the most common form of dementia. Moreover, the traditional mechanism of AD does not explain the microvascular damage observed in about 25-30 years between the onset of AD, which results in late application treatment that inhibits or delays neurodegeneration.ObjectiveOur objective was to identify differentially expressed genes in human brain samples Read More
-
-
-
Assessment of Early Vascular Aging Ambulatory Score (EVAAs): A Large Population-based External Validation Study
Authors: Christina Antza, Victoria Potoupni, Evangelos Akrivos, Stella Stabouli and Vasilios KotsisBackgroundPulse Wave Velocity (PWV) remains the gold-standard method to assess Early Vascular Aging (EVA) defined by arterial stiffness. However, its high cost, time-consuming process, and need for qualified medical staff shows the importance of identifying alternative methods for the EVA evaluation.ObjectiveIn order to simplify the process of assessing patient's EVA, we recently developed the Early Vascular Aging Read More
-
-
-
Burden of Ischemic Heart Diseases among US States from 1990-2019
BackgroundIschemic Heart Disease (IHD) is a leading cause of global mortality, including in the United States. Understanding the burden of IHD in the United States is crucial for informed decision-making and targeted interventions aimed at reducing morbidity and mortality associated with this leading cause of death. This study aimed to understand the burden of IHD, identify gender disparities and risk factors, explore the relati Read More
-
-
-
Bosentan and Pulmonary Hypertension Caused by COVID-19: A Pilot Randomized Double-blind Clinical Study
Authors: Fahime Shokrollahi, Ali Pazoki, Abbas Allami, Shahin Aliakbari and Kimia Rahimi ArdaliIntroduction/ObjectiveCoronavirus disease 2019 (COVID-19) has been the biggest pandemic in history, with severe complications, such as acute respiratory distress syndrome and pulmonary hypertension (PH). An endothelin-1 (ET-1) receptor antagonist, such as bosentan, may be beneficial in treating elevated ET-1 levels. Hence, our study aimed to evaluate the therapeutic effects of bosentan in patients with COVID-19-induced Read More
-
Volumes & issues
-
Volume 23 (2025)
-
Volume 22 (2024)
-
Volume 21 (2023)
-
Volume 20 (2022)
-
Volume 19 (2021)
-
Volume 18 (2020)
-
Volume 17 (2019)
-
Volume 16 (2018)
-
Volume 15 (2017)
-
Volume 14 (2016)
-
Volume 13 (2015)
-
Volume 12 (2014)
-
Volume 11 (2013)
-
Volume 10 (2012)
-
Volume 9 (2011)
-
Volume 8 (2010)
-
Volume 7 (2009)
-
Volume 6 (2008)
-
Volume 5 (2007)
-
Volume 4 (2006)
-
Volume 3 (2005)
-
Volume 2 (2004)
-
Volume 1 (2003)
Most Read This Month
Article
content/journals/cvp
Journal
10
5
false
en
